Bracco Diagnostics

LUMASON

Manufacturer:

Bracco Diagnostics

Lumason HCPCS:

Q9950

HCPCS Code Descriptor:

Injection, sulfur hexafluoride lipid microspheres, per ml

Category:

Q Code

Lumason NDCs:

00270-7097-07, 00270-7097-08, 00270-7099-16, 00270-7099-73

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Single-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00270-7097-08, 00270-7099-73, 00270-7099-16

About Lumason:

LUMASON is an Imaging/Radiopharmaceutical drug manufactured by Bracco Diagnostics and administered via the Injection route of administration. The Q Code: Q9950 is aligned to the drug LUMASON.

ACCESS PRICING AND MORE BY REGISTERING

Q9950 Added Date:

January 1, 2016

Q9950 Effective Date:

October 1, 2018

Q9950 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lumason billing and coding information.
Our team did not identify a source for Lumason patient assistance information. Please reach out to our team if you feel that this is a mistake.
LUMASON prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for LUMASON. Please check back in a few weeks.